Dossier
Caris Life Sciences
Coverage of Caris Life Sciences in the Nexus archive.
- STAT+: Pharmalittle: We’re reading about a bill to overhaul the 340B program, a new FDA commissioner candidate, and more
A bill introduced by Sen. Bill Cassidy (R-La.) aims to overhaul the 340B drug discount program by implementing restrictions such as retroactive rebates and sliding-fee scales for hospitals. Jeff Vacirca, a physician and leader of a New York oncology group, is among candidates being considered for FDA commissioner by the Trump administration.